Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Align Pharmaceuticals

2005 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Marketer of pharmaceuticals. The company is engaged in marketing drugs that are used to manage the effects of radiation or chemotherapy in cancer patients.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • 200 Connell Drive
  • Suite 1500
  • Berkeley Heights, NJ 07922
  • United States

Align Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Align Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Align Pharmaceuticals Executive Team (1)

Name Title Board
Seat
Contact
Info
William Collins President, Chief Executive Officer & General Manager